Hlengiwe Nombuso Mtetwa

Hlengiwe Nombuso Mtetwa

Auto-generated profile, based on publicly available information

Hlengiwe Nombuso Mtetwa

Department of Community Health Studies, Faculty of Health Sciences, Durban University of Technology, PO Box 1334, Durban, 4000, South Africa

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2022 in Heliyon
Verified
Journal Article
Open access
HMHlengiwe N. Mtetwa
Hlengiwe N. Mtetwa
IAIsaac D. Amoah
Isaac D. Amoah
SKSheena Kumari
Sheena Kumari
FBFaizal Bux
Faizal Bux
PRPoovendhree Reddy
Poovendhree Reddy
The surveillance of tuberculosis infections has largely depended on clinical diagnostics and hospitalization data. The advancement in molecular methods creates an opportunity for the adoption of alternative surveillance systems, such as wastewater-based epidemiology. This study presents the use of conventional and advanced polymerase chain reaction techniques (droplet digital PCR) to determine the occurrence and concentration of total mycobacteria and members of the Mycobacterium tuberculosis complex (MTBC) in treated and untreated wastewater. Wastewater samples were taken from three wastewater treatment plants (WWTPs) in the city of Durban, South Africa, known for a high burden of TB/MDR-TB due to HIV infections. All untreated wastewater samples contained total mycobacteria and MTBC at varying percentages per WWTP studied. Other members of the MTBC related to tuberculosis infection in animals, M. bovis and M. caprae were also detected. The highest median concentration detected in untreated wastewater was up to 4.9 (±0.2) Log10 copies/ml for total mycobacteria, 4.0 (±0.85) Log10 copies/ml for MTBC, 3.9 (±0.54) Log10 copies/ml for M. tuberculosis, 2.7 (±0.42) Log10 copies/ml for M. africanum, 4.0 (±0.29) Log10 copies/ml for M. bovis and 4.5 (±0.52) Log10 copies/ml for M. caprae. Lower concentrations were detected in the treated wastewater, with a statistically significant difference (P-value ≤ 0.05) in concentrations observed. The log reduction achieved for these bacteria in the respective WWTPs was not statistically different, indicating that the treatment configuration did not have an impact on their removal. The detection of M. africanum in wastewater from South Africa shows that it is possible that some of the TB infections in the community could be caused by this mycobacterium. This study, therefore, highlights the potential of wastewater-based epidemiology for monitoring tuberculosis infections.

20 July 2023 in Heliyon
Verified
Journal Article
Open access
HMHlengiwe N. Mtetwa
Hlengiwe N. Mtetwa
IAIsaac D. Amoah
Isaac D. Amoah
SKSheena Kumari
Sheena Kumari
FBFaizal Bux
Faizal Bux
PRPoovendhree Reddy
Poovendhree Reddy
The spread of multidrug-resistant tuberculosis (MDR-TB) is a serious public health issue, particularly in developing nations. The current methods of monitoring drug-resistant TB (DR-TB) using clinical diagnoses and hospital records are insufficient due to limited healthcare access and underreporting. This study proposes using Wastewater-Based Epidemiology (WBE) to monitor DR-TB in six African countries (Ghana, Nigeria, Kenya, Uganda, Cameroon, and South Africa) and examines the impact of treated wastewater on the spread of TB drug-resistant genes in the environment. Using droplet-digital polymerase chain reaction (ddPCR), the study evaluated untreated and treated wastewater samples in selected African countries for TB surveillance. There was a statistically significant difference in concentrations of genes conferring resistance to TB drugs in wastewater samples from the selected countries (p-value<0.05); South African samples exhibited the highest concentrations of 4.3(±2,77), 4.8(±2.96), 4.4(±3,10) and 4.7(±3,39) log copies/ml for genes conferring resistance to first-line TB drugs (katG, rpoB, embB and pncA respectively) in untreated wastewater. This may be attributed to the higher prevalence of TB/MDR-TB in SA compared to other African countries. Interestingly, genes conferring resistance to second-line TB drugs such as delamanid (ddn gene) and bedaquiline (atpE gene) were detected in relatively high concentrations (4.8(±3,67 and 3.2(±2,31 log copies/ml for ddn and atpE respectively) in countries, such as Cameroon, where these drugs are not part of the MDR-TB treatment regimens, perhaps due to migration or the unapproved use of these drugs in the country. The gene encoding resistance to streptomycin (rrs gene) was abundant in all countries, perhaps due to the common use of this antibiotic for infections other than TB. These results highlight the need for additional surveillance and monitoring, such as WBE, to gather data at a community level. Combining WBE with the One Health strategy and current TB surveillance systems can help prevent the spread of DR-TB in populations.

25 April 2023 in Environmental Research
Verified
Journal Article
Open access
HMHlengiwe N. Mtetwa
Hlengiwe N. Mtetwa
IAIsaac D. Amoah
Isaac D. Amoah
SKSheena Kumari
Sheena Kumari
FBFaizal Bux
Faizal Bux
PRPoovendhree Reddy
Poovendhree Reddy
Tuberculosis (TB) remains a persistent challenge to public health and presents a substantial menace, especially in developing nations of sub-Saharan Africa. It exerts a considerable strain on healthcare systems in these regions. Effective control requires reliable surveillance, which can be improved by incorporating environmental data alongside clinical data. Molecular advances have led to the development of alternative surveillance methods, such as wastewater-based epidemiology. This studyinvestigated the presence, concentration, and diversity of Mycobacterium tuberculosis complex, the cause of TB, in from six African countries: Ghana, Nigeria, Kenya, Uganda, Cameroon, and South Africa. Samples were collected from wastewater treatment plants. All samples were found to contain Mycobacterium species that have been linked to TB in both humans and animals, including Mycobacterium tuberculosis complex, Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium africanum, and Mycobacterium caprae, at varying concentrations. The highest median concentration was found in Ghana, reaching up to 4.7 Log copies/ml for MTBC, 4.6 Log copies/ml for M. bovis, and 3.4 Log copies/ml for M. africanum. The presence of M. africanum outside of West Africa was found in South Africa, Kenya, and Uganda and could indicate the spread of the pathogen. The study underscores the usefulness of wastewater-based epidemiology for tracking TB and shows that even treated wastewater may contain these pathogens, posing potential public health risks.

7 May 2024 in Heliyon
Verified
Journal Article
Open access
HMHlengiwe N. Mtetwa
Hlengiwe N. Mtetwa
IAIsaac D. Amoah
Isaac D. Amoah
SKSheena Kumari
Sheena Kumari
FBFaizal Bux
Faizal Bux
PRPoovendhree Reddy
Poovendhree Reddy
Wastewater-based epidemiology (WBE) is a robust tool for disease surveillance and monitoring of pharmaceutical consumption. However, monitoring tuberculosis (TB) drug consumption faces challenges due to limited data availability. This study aimed to optimise methods for detecting TB drugs in treated and untreated wastewater from four African countries: South Africa, Nigeria, Kenya, and Cameroon. The limit of detection (LOD) for these drugs ranged from a minimum of 2.20 (±1.02) for rifampicin to a maximum of 2.95 (±0.79) for pyrazinamide. A parallel trend was observed concerning the limit of quantification (LOQ), with rifampicin reporting the lowest average LOQ of 7.33 (±3.44) and pyrazinamide showing the highest average LOQ of 9.81 (±2.64). The variance in LOD and LOQ values could be attributed to factors such as drug polarity. Erythromycin and rifampicin exhibited moderately polar LogP values (2.6 and 2.95), indicating higher lipid affinity and lower water affinity. Conversely, ethambutol, pyrazinamide, and isoniazid displayed polar LogP values (-0.059, -0.6, and -0.7), suggesting lower lipid affinity and greater water affinity. The study revealed that storing wastewater samples for up to 5 days did not result in significant drug concentration loss, with concentration reduction remaining below 1 log throughout the storage period. Application of the optimised method for drug detection and quantification in both treated and untreated wastewater unveiled varied results. Detection frequencies varied among drugs, with ethambutol consistently most detected, while pyrazinamide and isoniazid were least detected in wastewater from only two countries. Most untreated wastewater samples had undetectable drug concentrations, ranging from 1.21 ng/mL for erythromycin to 54.61 ng/mL for isoniazid. This variability may suggest differences in drug consumption within connected communities. In treated wastewater samples, detectable drug concentrations ranged from 1.27 ng/mL for isoniazid to 10.20 ng/mL for ethambutol. Wastewater treatment plants exhibited variable removal efficiencies for different drugs, emphasising the need for further optimisation. Detecting these drugs in treated wastewater suggests potential surface water contamination and subsequent risks of human exposure, underscoring continued research's importance.

1 January 2022 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
HMHlengiwe Nombuso Mtetwa
Hlengiwe Nombuso Mtetwa
PRPoovendhree Reddy
Poovendhree Reddy
IAIsaac Dennis Amoah
Isaac Dennis Amoah
SKSheena Kumari
Sheena Kumari
FBFaizal Bux
Faizal Bux
The increasing prevalence of multidrug-resistant tuberculosis (MDR-TB) is a significant public health concern, particularly in developing countries. Surveillance of drug-resistant TB (DR-TB) using clinical diagnostics and hospitalization data is inadequate due to limited access to healthcare and underreporting. This study, therefore, applies the Wastewater-Based Epidemiology (WBE) approach to the surveillance of drug-resistant tuberculosis in six sub-Saharan African countries (Ghana, Nigeria, Kenya, Uganda, Cameroon, and South Africa) and the contribution of treated wastewater to the dissemination of genes conferring resistance tuberculosis treatment drugs into the environment. This study evaluated untreated wastewater and treated wastewater samples for TB surveillance in selected African countries using droplet-digital polymerase chain reaction (ddPCR). There was a statistically significant difference in concentrations of genes conferring resistance to TB drugs in wastewater samples from the selected countries (p-value<0.05); South African samples exhibited the highest concentrations of 4.3(±2,77), 4.8(±2.96), 4.4(±3,10) and 4.7(±3,39) log copies/ml for genes conferring resistance to first-line TB drugs (katG, rpoB, embB and pncA respectively) in untreated wastewater. This may be attributed to the higher prevalence of TB/MDR-TB in SA compared to other African countries. Other genes conferring resistance to second-line TB drugs such as delamanid (ddn gene) and bedaquiline (atpE gene) were detected in relatively high concentrations (4.8(±3,67 and 3.2(±2,31 log copies/ml for ddn and atpE respectively) in countries such as Cameroon where these drugs are not part of the MDR-TB treatment regimens. The gene encoding resistance to rrs gene for streptomycin was abundant in all countries due to the common use of this antibiotic for infections other than TB. These findings motivate the need for additional surveillance and monitoring to collect data at a community level. Early mitigation of the emergence and dissemination of drug-resistant TB in the population may be facilitated by integrating WBE and the One Health strategy.

17 September 2023 in ISEE Conference Abstracts
Verified
Journal Article
Open access
PRPoovendhree Reddy
Poovendhree Reddy
HMHlengiwe Nombuso Mtetwa
Hlengiwe Nombuso Mtetwa
Isaac Dennis AmoahIsaac Dennis Amoah
Isaac Dennis Amoah
SKSheena Kumari
Sheena Kumari
FBFaizal Bux
Faizal Bux